Anne C Le is a pharmacist who is specialized in Oncology in Lawrence, Massachusetts. Patients can reach her at 25 Marston St Apt 301, Lawrence or contact her on 978-996-0264. Active license number of Anne C Le is PH233320 for Oncology in Massachusetts. Anne C Le is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Anne C Le speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Anne C Le
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
25 Marston St Apt 301, Lawrence, Massachusetts, 01841-2358
Phone:
978-996-0264
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Anne C Le are as mentioned below.
NPI Number:
1902193022
NPI Enumeration Date:
10 Jul, 2011
NPI Last Update On:
05 Dec, 2018
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Anne C Le are as mentioned below.
Specialization
License Number
State
Status
Oncology
PH233320
Massachusetts
Primary
Pharmacist
PH233320
Massachusetts
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
25 Marston St Apt 301, Lawrence, Massachusetts
Zip:
01841-2358
Phone Number:
978-996-0264
Fax Number:
--
Patients can reach Anne C Le at 25 Marston St Apt 301, Lawrence, Massachusetts or can call on phone at 978-996-0264.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.